Promising Method For Early Diagnosis Of Cancer

Promising Method For Early Diagnosis Of Cancer.
A collaboration of US scientists and secluded companies are looking into a study that could find even one stray cancer stall among the billions of cells that circulate in the human bloodstream. The hope is that one day such a test, given soon after a therapy is started, could indicate whether the therapy is working or not. It might even indicate beforehand which remedying would be most effective more helpful hints. The test relies on circulating tumor cells (CTCs) - cancer cells that have isolated from the main tumor and are traveling to other parts of the body.

In 2007, researchers at Massachusetts General Hospital, developed a "microfluidic chip," called CellSearch, which could compute the number of lost cancer cells, but that test didn't allow scientists to trap whole cells and analyze them vigrxbox. But on Monday, Mass General announced an compact with Veridex LLC, unit of Johnson & Johnson, to study a newer version of the test.

According to the Associated Press, the updated proof requires only a couple of teaspoons of blood. The microchip is dotted with tens of thousands of microscopic posts covered with antibodies designed to stick to tumor cells. As blood passes over the chip, tumor cells away from the pack and adhere to the posts.